Professor Aviv Regev, PhD, is Executive Vice President and Global Head of Genentech Research and Early Development at the biotechnology company Genentech, a member of the Roche Group. Prior to Genentech, Regev served as founding director of the Klarman Cell Observatory at the Broad Institute, Professor of Biology at MIT, and Investigator of the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas. Aviv Regev has pioneered the development of foundational experimental and computational methods in single-cell genomics and is a leader in deciphering molecular circuits that govern cells, tissues, and organs in health and disease. Among many honors, she is an elected member of the National Academy of Sciences and the National Academy of Medicine in the United States.
For her outstanding research, Prof. Aviv Regev, PhD, is awarded the 2021 Ernst Schering Prize.